Aug 14, 2025 20:18
DARE - Dare Bioscience, Inc. Common Stock
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
2.06 0.0 (0.0%) | --- | --- | --- | 0.0 (0.0%) | 0.0 (0.0%) | --- | 0.0 (0.0%) |
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
Earnings & Ratios
- Basic EPS:
- -0.45
- Diluted EPS:
- -0.45
- Basic P/E:
- -4.5778
- Diluted P/E:
- -4.5778
- RSI(14) 1m:
- 49.66
- VWAP:
- 2.06
- RVol:
- 0.8745
Events
Period | Kind | Movement | Occurred At |
---|---|---|---|
1m | Price decrease 1m | 2.05 -0.03 (-1.44%) | Oct 15 12:38 |
1m | Price increase 1m | 2.1 +0.04 (+1.94%) | Oct 15 11:46 |
1m | Price increase 1m | 2.09 +0.03 (+1.42%) | Oct 15 09:48 |
Related News
Jul 21, 2025 17:47
Aug 13, 2024 12:00
Jul 19, 2024 18:09
Jul 19, 2024 12:03
Jun 27, 2024 12:00
Apr 23, 2024 12:00
Mar 21, 2024 12:00
Jan 31, 2024 13:00
Jan 26, 2024 21:30